Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z. Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L. Gartel

Journal title: Cell Death Discovery

Journal number: 10

Journal publisher: Springer Science and Business Media LLC

Published year: 2024

DOI identifier: 10.1038/s41420-024-01929-0

ISSN: 2058-7716